For Research & Science Partners
MeScreen supports research teams, universities, biotech companies and science-led partners exploring mitochondrial function, cellular resilience, oxidative stress and longitudinal wellness data. Our platform can help structured studies collect functional cellular health insight through a scalable at-home sample model and partner laboratory analysis.
MeScreen can support research and science partners with mitochondrial function testing, dried blood spot sample workflows, digital reporting and study-aligned deployment. It is suited to observational research, programme evaluation, wellness intervention studies and partner-led validation work where cellular health insight is useful and governance, consent and data controls are defined before launch.
Mitochondria sit at the intersection of energy metabolism, oxidative stress, ageing biology, physical performance and recovery. For research teams, the opportunity is not to oversell a single marker. It is to measure cellular function carefully, align it with study design and interpret it alongside behavioural, clinical, metabolic or performance data.
The 2023 Hallmarks of Aging update in Cell includes mitochondrial dysfunction among major biological processes associated with ageing. That makes mitochondrial function relevant to healthspan research, intervention studies and mechanistic exploration.
At-home dried blood spot collection can reduce participant friction, support geographically distributed cohorts and make repeated sampling more feasible than clinic-only workflows.
The existing MeScreen journey includes at-home collection, laboratory analysis and secure digital reporting. Research partnerships can adapt that operational model to the protocol, governance and data needs of the study.
MeScreen can add a cellular function layer to studies that already collect symptom, lifestyle, wearable, metabolic or performance data. That is useful where the research question involves energy, resilience, fatigue, recovery or biological response to an intervention.
Baseline and follow-up testing can support research into nutrition, exercise, sleep, recovery, stress management, corporate wellbeing or clinic-led protocols. The strongest designs define timing, endpoints and interpretation rules before participants are enrolled.
At-home dried blood spot workflows can reduce operational burden. For the right study, participants can collect samples outside a clinic, improving convenience while preserving a structured chain of instructions, consent and laboratory processing.
MeScreen can support academic research, biotech exploration, corporate wellness evaluation, clinic validation projects and white-label data partnerships. Scope, governance and publication rights should be agreed before work begins.
Research value depends on trust. Any MeScreen research partnership should define consent, participant information, data minimisation, anonymisation, storage, analysis responsibilities, ethics requirements and publication rights before recruitment begins. Where a study makes clinical claims or involves patient populations, the appropriate ethics, regulatory and professional approvals must sit with the study sponsor.
MeScreen can discuss protocol fit, sample logistics, cohort size, data needs, reporting structure, partnership terms and operational constraints. Start with the research question; the testing model should serve that question, not the other way round.
Start a research partnership conversationMeScreen can support research into mitochondrial function, cellular resilience, oxidative stress, fatigue, recovery, lifestyle interventions, wellness programmes and healthspan-related questions where functional cellular insight is relevant.
Yes. Baseline and follow-up testing is a strong use case, provided the study defines timing, endpoints, participant instructions and analysis rules before data collection starts.
No. MeScreen is a wellness and functional laboratory assessment unless a separate research protocol, ethics approval and clinical governance framework establishes a specific clinical pathway. It should not be described as a diagnostic test by default.
Aggregate or study-level data access can be discussed as part of a formal partnership. Data access depends on consent, protocol design, privacy controls, commercial terms and applicable data protection requirements.
Yes. MeScreen can explore collaborations with academic institutions, biotech companies, digital health teams, clinic networks and corporate research partners where the scientific question is aligned with mitochondrial or cellular health insight.
Prepare the research question, target cohort, sample size estimate, proposed endpoints, testing timeline, data access needs, ethics status and whether the work is academic, commercial or mixed.